We could not find any results for:
Make sure your spelling is correct or try broadening your search.
| Ticker | Name | Price | Change | Change % | Volume |
|---|---|---|---|---|---|
| Vast Renewable Ltd | 0.9811 | 0.4812 | 96.26% | 62,769,170 | |
| Healthcare Triangle Inc | 0.47 | 0.145 | 44.62% | 19,085,745 | |
| Oncology Institute Inc | 0.903 | 0.272 | 43.11% | 4 | |
| Home Federal Bancorp Inc of Louisiana | 17.99 | 5.36 | 42.38% | 1 | |
| CSP Inc | 22.00 | 6.50 | 41.94% | 16 | |
| L B Foster Company | 25.99 | 6.15 | 31.00% | 7 | |
| AleAnna Inc | 6.93 | 1.60 | 30.02% | 199 | |
| Distribution Solutions Group Inc | 38.99 | 8.45 | 27.67% | 14 | |
| Daxor Corporation | 9.94 | 2.15 | 27.65% | 3 | |
| EW Scripps Company | 1.80 | 0.37 | 25.87% | 2,638,981 | |
| Synchronoss Technologies Inc | 8.96 | 1.83 | 25.67% | 6,594 |
Goldman Brings Proven Record of Overseeing Successful Operational and Financial Transformations Expands Size of Board to Nine Directors BEDFORD, Mass., March 12, 2025 /PRNewswire/ --Â iRobot Corp. (NASDAQ: IRBT), a leader in consumer robots, today announced the addition of Neal P. Goldman as an independent director to its Board of Directors, effective immediately, expanding the size of the Board to nine directors, eight of whom are independent.
ENGLEWOOD, Colo., March 11, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today reported its financial and operational results for the fourth quarter and full year ended December 31, 2024.
CINCINNATI, March 11, 2025 /PRNewswire/ -- The E.W. Scripps Company (NASDAQ: SSP) delivered $728 million in revenue for the fourth quarter of 2024, driven by record political advertising revenue. Income attributable to the shareholders of Scripps was $80.3 million or 92 cents per share.
A live webcast of the conference call will be available on the Company's website at https://ir.nrxpharma.com/events. Participants that are unable to join the webcast can access the conference call via telephone by dialing domestically +1-800-717-1738 or internationally +1-646-307-1865.  NRx Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of central nervous system disorders, specifically suicidal bipolar depression, chronic pain, and PTSD. The Company is developing NRX-101, an FDA-designated investigational Breakthrough Therapy for suicidal treatment-resistant bipolar depression and chronic pain. NRx plans to file an NDA for Accelerated Approval for NRX-101 in patients with ...
| Ticker | Name | Price | Change | Change % | Market Cap | Volume |
|---|---|---|---|---|---|---|
| Bitcoin | 82,940.87 | 90.97 | 0.11% | 1.64T | 7,055,312,530 | |
| Ethereum | 1,911.95 | -7.76 | -0.40% | 230.43B | 3,292,883,187 | |
| Tether USD | 0.99966 | -0.00005 | -0.01% | 141.88B | 508,450,911 | |
| Ripple | 2.20 | 0.030 | 1.38% | 127.08B | 1,587,025,396 | |
| Binance Coin | 558.69 | 7.40 | 1.34% | 88.25B | 328,564,512 | |
| Solana | 126.93 | 1.78 | 1.42% | 61.72B | 1,195,299,032 | |
| USD Coin | 0.9999 | 0.00 | 0.00% | 56.09B | 1,214,106,268 | |
| Cardano | 0.7385 | 0.0156 | 2.16% | 26.55B | 501,231,674 | |
| Dogecoin | 0.16836 | 0.00419 | 2.55% | 24.85B | 610,102,582 | |
| TRON | 0.221903 | -0.002522 | -1.12% | 19.18B | 239,055,181 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions